NYSE · IH

iHuman Inc.. American , each representing five

$1.35 -$0.10 (-6.92%) 1D Market open

Key Metrics

$73.86M
Market cap
P/E · TTM
Revenue · TTM
Net income
EPS · TTM
Dividend yield 7.6%
Free cash flow $6.64M
Beta · 1Y 0.23
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 27
    From its Feb 11 high, the share price fell 35%.

    Peak close $2.06 on Feb 11; trough close $1.35 on Jul 27. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -35%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 10
    The stock moved +9.6% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 10
  • Mar 18
    The stock moved +9.9% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 18

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$73.86M
Enterprise value
Shares outstanding51.1M
52-wk range$1.33 – $3.16
Avg volume · 20D31.1K
Net cash
Book value / share$2.78
ExchangeNYSE
About iHuman Inc.. American , each representing five
IPO dateOct 9, 2020
Employees558

iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S
P/FCF11.13
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating
Net
FCF
ROE / ROIC — · —

Financial Health

Current ratio3.57
Quick ratio3.51
Debt / equity
Debt / EBITDA
Net cash
Working capital$133.62M

Cash Flow · TTM

Operating CF $7.34M
Capex −$701.00K
Free cash flow $6.64M
Buybacks $2.46M
Dividends paid $5.59M
Shareholder yield 10.9%

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2025-12-31 · computed by TickerWolf from SEC filings